AMGN

Nasdaq

AMGEN INC

Health Care, Biotechnology

$410.95

close 7 Aug 2026

+44.15%

52-week change

$222.16B

market cap

$269.77

$418.40

52-week range

Valuation

Market cap$222.16B

P/E (TTM / 5y avg)25.54x26.68x

Forward P/E (FY2026 / FY2027)17.97x17.12x

PEG (TTM / fwd)4.623.60

P/S (TTM)5.83x

P/B19.01x

EV/EBITDA (TTM)16.26x

FCF yield (TTM)4.58%

Cash flow & dividend

FCF (TTM)$10.18B

FCF per share (TTM)$18.82

FCF margin (TTM)26.71%

Dividend yield (indicated / 5y avg)2.45%3.14%

Annualized dividend$10.08

Payout ratio (EPS / FCF)60.45%51.94%

Growth & quality

Revenue YoY, latest Q+9.53%

Diluted EPS YoY, latest Q+64.91%

Operating margin (TTM)29.99%

Net margin (TTM)22.95%

ROE (latest FY)89.06%

Net debt / EBITDA (TTM)2.65

Interest coverage (TTM)4.28

Price

+78.92%+12.38%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +7.65%10Y CAGR +5.43%

Diluted EPS

5Y CAGR +2.94%10Y CAGR +4.62%

FCF per share

5Y CAGR -2.26%10Y CAGR +2.28%

Operating cash flow

5Y CAGR -1.05%10Y CAGR +0.23%

Free cash flow

5Y CAGR -3.91%10Y CAGR -1.20%

Dividends per share

5Y CAGR +8.24%10Y CAGR +11.70%

Payout ratio

FCF payout ratio

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR -1.41%10Y CAGR -3.30%

Net debt / EBITDA

Interest coverage

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date2 Nov 2026amc

EPS estimate$5.87

Revenue estimate$9.86B

Last reported

Date—

EPS——

Revenue——